AHPA, CHPA, CRN, and UNPA say placing ODS under the Office of Nutrition Research would add a layer of bureaucracy. NIH is accepting comments through October 28.
|Articles|January 20, 2023
Nuliv Science gains NPN from Health Canada for Astrion skin-health ingredient
Author(s)Jennifer Grebow
Astrion is a combination of Centella asiatica and Astragalus membranaceus that the company says has been clinically shown to support skin health.
Advertisement
Health Canada has granted Nuliv Science’s (Brea, CA) Astrion skin-health ingredient a Natural Product Number (NPN) enabling the ingredient to be sold as a natural health product in Canada. A NPN is awarded after Health Canada assesses an ingredient for safety, efficacy, and quality.
Astrion is a combination of Centella asiatica and Astragalus membranaceus that the company says has been clinically shown to support skin health.
In a press release, Richard Wang, CEO of Nuliv Science, called the newly awarded NPN “a testament to the safety, quality, and effectiveness of our ingredient.”
Advertisement
Related to this article
Todd Harrison, co-chair of the FDA practice group at Venable LLP, explains how California’s AB 2779 changes date-labeling requirements for supplements, why stability testing matters, and how companies can navigate evolving state rules while advocating for federal uniformity.
FDA's final NDI guidance sets identity and safety expectations. See what AHPA and CRN say remains unresolved and what it means for suppliers.
The agency’s editorial identifies needs across six areas, including new methods for novel products, gut microbiome data, and AI-supported risk assessment.
The Council for Responsible Nutrition says its Morning Consult survey also found that three in four adults use supplements and that cost is the most commonly cited barrier.
The proposed notification requirement is straightforward, but its legal and commercial consequences are not.
The trade group says the denial does not settle its concerns about a law that limits minors' access to supplements marketed for weight loss or muscle building, and the case now returns to district court.
From targeted benefits to new delivery formats, a roundup of recent beauty-from-within research, formats, and product launches.
Advertisement
Advertisement